This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Biosteed Gene Expression Tech. Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Lu Zhuang: Innovator in Biopharmaceuticals
Introduction
Lu Zhuang is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of modified interferons. With a total of 2 patents, his work focuses on enhancing the efficacy of treatments for viral infections.
Latest Patents
Lu Zhuang's latest patents include innovative methods for modifying interferon alpha-2a and interferon alpha-2b using polyethylene glycol (PEG). The first patent details the modification of interferon alpha-2a at a specific lysine residue with a Y-shaped branched PEG derivative. This modification aims to improve the medicinal use of interferon alpha-2a. The second patent involves a similar modification for interferon alpha-2b, which can be utilized in creating a medicament for treating diseases such as Hepatitis C.
Career Highlights
Lu Zhuang is currently associated with Biosteed Gene Expression Tech Co., Ltd. His work at this company has been pivotal in advancing research and development in gene expression technologies. His innovative approaches have positioned him as a key player in the biopharmaceutical industry.
Collaborations
Lu Zhuang collaborates with esteemed colleagues, including Weidong Zhou and Qingjiang Xiao. Their combined expertise fosters a productive research environment that drives innovation in their field.
Conclusion
Lu Zhuang's contributions to biopharmaceuticals through his patented innovations highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile